Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ashok Leyland Ltd
BSE:500477
|
IN |
|
R
|
Revolution Co Ltd
TSE:8894
|
JP |
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
US |
|
Kanabo Group PLC
LSE:KNB
|
UK |
|
GigaDevice Semiconductor Inc
SSE:603986
|
CN |
|
Kore Potash PLC
LSE:KP2
|
UK |
|
D
|
Douglas Elliman Inc
NYSE:DOUG
|
US |
|
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
US |
|
Alphawave IP Group PLC
LSE:AWE
|
UK |
|
MDJM Ltd
NASDAQ:UOKA
|
UK |
|
Banco Products (India) Ltd
NSE:BANCOINDIA
|
IN |
|
China Citic Bank Corp Ltd
SSE:601998
|
CN |
|
Alexander & Baldwin Inc (Hawaii)
NYSE:ALEX
|
US |
|
Lippo General Insurance Tbk PT
IDX:LPGI
|
ID |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
US |
|
C
|
China Star Food Group Ltd
SGX:42W
|
SG |
|
HPQ Silicon Resources Inc
XTSX:HPQ
|
CA |
|
Valiant Holding AG
SIX:VATN
|
CH |
|
K
|
Korea Line Corp
KRX:005880
|
KR |
|
P
|
P10 Inc
NYSE:PX
|
US |
|
C
|
CompX International Inc
AMEX:CIX
|
US |
|
22nd Century Group Inc
NASDAQ:XXII
|
US |
|
S
|
Sai Gon Mien Trung Beer JSC
VN:SMB
|
VN |
Cumberland Pharmaceuticals Inc
Intangible Assets
Cumberland Pharmaceuticals Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Intangible Assets
$14m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-4%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Intangible Assets
$50.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Intangible Assets
$19.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
30%
|
|
|
Pfizer Inc
NYSE:PFE
|
Intangible Assets
$53.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
14%
|
CAGR 10-Years
3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Intangible Assets
$26.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Intangible Assets
$6.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
Cumberland Pharmaceuticals Inc
Glance View
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. The company is headquartered in Nashville, Tennessee and currently employs 83 full-time employees. The company went IPO on 2009-08-11. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.
See Also
What is Cumberland Pharmaceuticals Inc's Intangible Assets?
Intangible Assets
14m
USD
Based on the financial report for Dec 31, 2025, Cumberland Pharmaceuticals Inc's Intangible Assets amounts to 14m USD.
What is Cumberland Pharmaceuticals Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
-4%
Over the last year, the Intangible Assets growth was -22%. The average annual Intangible Assets growth rates for Cumberland Pharmaceuticals Inc have been -23% over the past three years , -13% over the past five years , and -4% over the past ten years .
